The Hemoglobinopathies Market is expected to increase at a CAGR of 10.37 percent, from USD 6.75 billion in 2020 to USD 14.86 billion in 2027.
The global Hemoglobinopathy Market is anticipated to be worth USD 15.7 billion. From 2021 to 2028, it is predicted to grow at a CAGR of 10.8%. Over the forecast period, rising awareness of hemoglobinopathies and government attempts to diagnose the disorders at an early stage are expected to drive market growth. Furthermore, rising R&D spending, a promising drug pipeline, and technologically advanced diagnostics platforms are projected to propel the market forward.
Read more @ https://cmilatestinsights.blogspot.com/2022/02/global-study-on-hemoglobinopathy-market.html
